
A recent study assessed a screening strategy's efficacy for identifying RTH-α in 432 children with normo- or macrocytic anaemia at paediatric neurology clinics. Of the 32 subjects analyzed, one was diagnosed with RTH-α. Clinical and biochemical evaluations, including THRA sequencing, were conducted. Notably, normo- or macrocytic anaemia resolved in 47% of cases. The screening strategy, incorporating clinical and laboratory features, offers a targeted approach for identifying RTH-α, reducing unnecessary genetic analyses in neurological cases. The study's findings provide valuable insights for optimizing diagnostic protocols.
Like
Save
Share